Gastroenterology · 2018 · 87 citations · 11 references
PharmacyImmunologyPharmacotherapyClinical PharmacologyImmunotherapyRheumatologyAnti-inflammatory PharmacologyCrohn Disease PharmacotherapyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Disease PharmacotherapyUlcerative Colitis PharmacotherapyClinical RemissionDouble-blind TrialsDurable Clinical ResponseInflammatory Bowel Disease Activity AssessmentInflammatory Bowel Disease TherapyIntegrin InhibitorsMucosal Healing ResponsePlacebo-controlled Efficacy Assessment
11
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 453 citations · Full text